Latest updates for Ms Relapse

Fresh curated links around MS relapse are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Blood test may help doctors spot MS relapses sooner, study shows
  • MS breakthrough as researchers find new way to spot previously undetectable brain lesions - as cases surge in young peop
  • Guide to oral steroids and multiple sclerosis relapses

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

multiplesclerosisnewstoday.com /2 days ago

Blood test may help doctors spot MS relapses sooner, study shows

A test using data from 18 blood biomarkers to track disease activity in multiple sclerosis (MS) was able to distinguish true MS relapses from symptom worsening unrelated to active...

Read source
dailymail.com /1 week ago

MS breakthrough as researchers find new way to spot previously undetectable brain lesions - as cases surge in young peop...

Commonly known as MS, multiple sclerosis is a debilitating disease in which the immune system mistakenly attacks the body's nervous system. It affects around 150,000 people in the...

Read source
multiplesclerosisnewstoday.com /1 month ago

Guide to oral steroids and multiple sclerosis relapses

Living with multiple sclerosis (MS) can sometimes mean dealing with relapses, when new or worsening symptoms appear. To help shorten these flare-ups and make them less intense, doc...

Read source
multiplesclerosisnewstoday.com /4 weeks ago

MS relapses rare after age 60 whether DMTs continued or stopped

People with multiple sclerosis (MS) who were older than 60 had a low risk of disease flares whether they continued or stopped taking disease-modifying therapies (DMTs), according t...

Read source
multiplesclerosisnewstoday.com /3 weeks ago

Late-onset MS linked to relapse-free disability progression: Study

People who develop multiple sclerosis (MS) at age 50 or later are more likely to accumulate disability through mechanisms that are not directly linked to relapses or MRI activity t...

Read source
multiplesclerosisnewstoday.com /2 weeks ago

MMR, chickenpox vaccines don’t trigger MS relapses, study finds

Measles-mumps-rubella (MMR) and chickenpox (varicella) vaccines do not increase the risk of relapse for people with multiple sclerosis (MS), according to a study involving more tha...

Read source
multiplesclerosisnewstoday.com /1 month ago

Small fatty molecules may predict future relapse risk in early MS: Study

Among people with clinically isolated syndrome (CIS) — an initial episode of symptoms suggestive of multiple sclerosis (MS) — lower levels of certain fatty molecules in the blood a...

Read source
multiple-sclerosis-research.org /1 month ago

PIRA, PIRMA, RAW, MAW is it SH1-In, SH1-Out? We need to target different processes to those targeting relapses to limit...

Tur C. High-efficacy therapy and progression independent of relapse and MRI activity in multiple sclerosis. Brain. 2026:awag175. https://doi.org/10.1093/brain/awag175 They say “The...

Read source
emdocs.net /1 month ago

Shift Pearls: Multiple Sclerosis

Shifts pearls returns with multiple sclerosis. The post Shift Pearls: Multiple Sclerosis appeared first on emDocs.

Read source
multiplesclerosisnewstoday.com /1 month ago

Multiple lesions on spinal cord signal a 2 times higher risk of MS, per study

The presence of multiple asymptomatic spinal cord lesions — areas of damage, as captured by imaging scans — is associated with about a twofold higher risk of developing multiple sc...

Read source
multiple-sclerosis-research.org /1 month ago

Switching made easier

Schoof LG, Hogenboom L, van Kempen ZL, Killestein J, van Oosten BW, Strijbis EM. Reinitiating ocrelizumab with a full 600 mg dose after extended treatment interruption: No increa...

Read source
multiple-sclerosis-research.org /3 weeks ago

Extending the intervals

Rituximab, ocrelizumab and ublituximab is given every 24 weeks This is done to maintain a low levels of B cell numbers. If you spend the time and expense to measure the reappearanc...

Read source
bioengineer.org /1 month ago

Rethinking Multiple Sclerosis Prognosis with Multiaxial Approach

In a groundbreaking shift in understanding multiple sclerosis (MS), researchers from the Magnetic Resonance Imaging in MS (MAGNIMS) consortium have unveiled a transformative approa...

Read source
multiplesclerosisnewstoday.com /3 weeks ago

Taking high-dose vitamin D daily over the long term helps reduce MS relapses

Taking high-dose vitamin D supplements for more than a year can significantly cut relapse risks and ease disability for people with multiple sclerosis (MS), according to a comprehe...

Read source
multiplesclerosisnewstoday.com /2 weeks ago

Routine MRI measure may flag higher risk of MS progression

Changes in the upper part of the spinal cord may help identify people with relapsing-remitting multiple sclerosis (RRMS) who are at higher risk of converting to the secondary progr...

Read source
multiplesclerosisnewstoday.com /3 days ago

Learning new skills could promote myelin repair in MS patients

Rehabilitation strategies aimed at learning new skills may promote myelin repair in people with multiple sclerosis (MS), said scientists, who called for more research to test these...

Read source
multiple-sclerosis-research.org /1 month ago

Three types of Progressive Disability

The CONSONANCE trial was a trial of ocrelizumab De Meo E, Jolly AE, Ganzetti M, Prados Carrasco F, Kanber B, Stutters J, McManus D, Kazlauskaite A, Craveiro L, Eshaghi A, Cole J, C...

Read source
multiplesclerosisnewstoday.com /6 days ago

Don’t disconnect: How to stay socially active during an MS flare-up

Multiple sclerosis (MS) is a chronic condition that can cause a wide range of symptoms. Because the symptoms are so broad, and sometimes unpredictable, some people living with MS m...

Read source
multiple-sclerosis-research.org /4 weeks ago

Beware…Get Diagnosed Get Treated effectively

What causes progression?…Many things….some we can do something about and early effective treatment is one of the them. Yep you know this already. Get diagnosed and treated. Disabil...

Read source
multiplesclerosisnewstoday.com /3 weeks ago

Researchers identify new therapeutic targets to combat MS progression

Scientists have identified six proteins that could serve as targets for new treatments designed to slow multiple sclerosis (MS) progression. The data showed that one protein, RRM2B...

Read source
multiplesclerosisnewstoday.com /1 month ago

CMSC 2026: Kesimpta outperforms Aubagio in highly active relapsing MS

Kesimpta (ofatumumab) was more effective than Aubagio (teriflunomide) at suppressing disease activity in people with highly active, relapsing forms of multiple sclerosis (MS), acco...

Read source
multiplesclerosisnewstoday.com /1 month ago

Managing sudden MS symptoms in public

Jennifer Powell, shares how she prepares for symptom flares in public, including heat sensitivity, falls, and communication challenges. The post Managing sudden MS symptoms in pub...

Read source
neurosciencenews.com /5 days ago

Myelin Damage Triggers Abnormal Brain Rhythms During Sleep

Demyelination triggers abnormal, epileptiform electrical spikes coupled with Stage 2 NREM sleep spindles and induces a severe slowing of rhythmic REM sleep oscillations, establishi...

Read source
multiple-sclerosis-research.org /2 weeks ago

Multiple Sclerosis is Serious.Treat it Seriously (Part 3)

The NHS drug use data was discovered and brought to my attention by Dom and he and Melissa did the analysis and wrote a paper (below). This was sent to review. The referees wanted...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Ms Relapse

dailymail.co.uk

Recent coverage from public sources
Public source

emdocs.net

Recent coverage from public sources
Public source

bioengineer.org

Recent coverage from public sources
Public source

multiple-sclerosis-research.org

Recent coverage from public sources
Public source

multiplesclerosisnewstoday.com

Recent coverage from public sources
Public source

neurosciencenews.com

Recent coverage from public sources
Public source